Matthew Cooper, Phd
Pharmecuticals,biotechnology
adeniumbiotech
Denmark
Biography
he completed phyd in 1995 and llived for 15 years in uk.University of Cambridge, then 9 years in start-ups and biotechnology companies. He returned to Australia in 2009 as a NHMRC Australia Fellow, at the University of Queensland, where he is currently driving new antibiotic and bacterial diagnostic R&D. He was Managing Director of Cambridge Medical Innovations (part of Alere Inc.) and CSO of Akubio, and has more than 100 scientific articles, 2 books, 20 patents, and has helped launch many products on the market today.
Research Interest
he is currently driving new antibiotic and bacterial diagnostic R&D. He was Managing Director of Cambridge Medical Innovations (part of Alere Inc.) and CSO of Akubio, and has more than 100 scientific articles, 2 books, 20 patents, and has helped launch many products on the market today.
